{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:48:10Z","timestamp":1792176490216,"version":"4.4.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1038\/s41372-021-01271-8","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T19:04:14Z","timestamp":1637089454000},"page":"293-299","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Methamphetamine: burden, mechanism and impact on pregnancy, the fetus, and newborn"],"prefix":"10.1038","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-6949","authenticated-orcid":false,"given":"Deepika","family":"Sankaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6098-2155","authenticated-orcid":false,"given":"Satyan","family":"Lakshminrusimha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veena","family":"Manja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"1271_CR1","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/S0022-3476(89)80661-4","volume":"115","author":"SD Dixon","year":"1989","unstructured":"Dixon SD, Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: Incidence and clinical correlates. J Pediatrics. 1989;115:770\u2013778. https:\/\/doi.org\/10.1016\/S0022-3476(89)80661-4","journal-title":"J Pediatrics"},{"key":"1271_CR2","first-page":"436","volume":"150","author":"SD Dixon","year":"1989","unstructured":"Dixon SD. Effects of transplacental exposure to cocaine and methamphetamine on the neonate. West J Med. 1989;150:436.","journal-title":"West J Med"},{"key":"1271_CR3","unstructured":"NIDA. What are the risks of methamphetamine misuse during pregnancy?. National Institute on Drug Abuse website. https:\/\/www.drugabuse.gov\/publications\/research-reports\/methamphetamine\/what-are-risks-methamphetamine-misuse-during-pregnancy. April 13, 2021 Accessed September 30, 2021."},{"key":"1271_CR4","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1161\/atvbaha.119.312461","volume":"39","author":"CG Kevil","year":"2019","unstructured":"Kevil CG, Goeders NE, Woolard MD, Bhuiyan MS, Dominic P, Kolluru GK, et al. Methamphetamine Use and Cardiovascular Disease. Arteriosclerosis, thrombosis, Vasc Biol. 2019;39:1739\u201346. https:\/\/doi.org\/10.1161\/atvbaha.119.312461","journal-title":"Arteriosclerosis, thrombosis, Vasc Biol"},{"key":"1271_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/1057567717730104","volume":"28","author":"DM Stoneberg","year":"2018","unstructured":"Stoneberg DM, Shukla RK, Magness MB. Global methamphetamine trends: an evolving problem. Int Crim justice Rev. 2018;28:136\u201361.","journal-title":"Int Crim justice Rev"},{"key":"1271_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.eclinm.2019.09.014","volume":"16","author":"R McKetin","year":"2019","unstructured":"McKetin R, Leung J, Stockings E, Huo Y, Foulds J, Lappin JM, et al. Mental health outcomes associated with of the use of amphetamines: A systematic review and meta-analysis. EClinicalMedicine. 2019;16:81\u201397. https:\/\/doi.org\/10.1016\/j.eclinm.2019.09.014","journal-title":"EClinicalMedicine"},{"key":"1271_CR7","doi-asserted-by":"publisher","first-page":"4050932","DOI":"10.1155\/2017\/4050932","volume":"2017","author":"JR Richards","year":"2017","unstructured":"Richards JR, Hamidi S, Grant CD, Wang CG, Tabish N, Turnipseed SD, et al. Methamphetamine use and emergency department utilization: 20 years later. J Addict. 2017;2017:4050932\u20134050932. https:\/\/doi.org\/10.1155\/2017\/4050932","journal-title":"J Addict"},{"key":"1271_CR8","unstructured":"UNODC. World Drug Report 2020. United Nations Office on Drugs and Crime;https:\/\/wdr.unodc.org\/wdr2020\/field\/WDR20_Booklet_2.pdf, 18- 25 (2020)."},{"key":"1271_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2147\/DMSO.S95299","volume":"10","author":"EJ Hendricks","year":"2017","unstructured":"Hendricks EJ. Off-label drugs for weight management. Diabetes Metab Syndr Obes. 2017;10:223\u201334. https:\/\/doi.org\/10.2147\/DMSO.S95299","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1271_CR10","unstructured":"Elinore F. McCance-Katz, M, PhD. Substance Abuse and Mental Health Services Administration. The National Survery on Drug Use and Health: 2018. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/cbhsq-reports\/Assistant-Secretary-nsduh2018_presentation.pdf, 36-37 (2018)."},{"key":"1271_CR11","unstructured":"Administration., SAAMHS Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https:\/\/www.samhsa.gov\/data\/. (2020)."},{"key":"1271_CR12","unstructured":"Artigiani EE, Hsu MH, McCandlish D, and Wish ED Methamphetamine: a Regional Drug Crisis. National Drug Early Warning System 2018 https:\/\/cesar.umd.edu\/sites\/cesar.umd.edu\/files\/pubs\/ndews-scs-methamphetamine-report-september-2018-final.pdf, 2\u20136 (2018)."},{"key":"1271_CR13","doi-asserted-by":"publisher","unstructured":"Han B, Compton WM, Jones CM, Einstein EB & Volkow, ND Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults. JAMA Psychiatry. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.2588 (2021).","DOI":"10.1001\/jamapsychiatry.2021.2588"},{"key":"1271_CR14","unstructured":"Customs US, P. B. CBP enforcement statistics FY 2021. US Department of Homeland Security, Washington, DC. https:\/\/www.cbp.gov\/newsroom\/stats\/drug-seizure-statistics (2021)."},{"key":"1271_CR15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","volume":"75","author":"D Sulzer","year":"2005","unstructured":"Sulzer D, Sonders MS, Poulsen NW, Galli A. Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol. 2005;75:406\u201333. https:\/\/doi.org\/10.1016\/j.pneurobio.2005.04.003","journal-title":"Prog Neurobiol"},{"key":"1271_CR16","doi-asserted-by":"publisher","first-page":"e183758","DOI":"10.1001\/jamanetworkopen.2018.3758","volume":"1","author":"TNA Winkelman","year":"2018","unstructured":"Winkelman TNA, Admon LK, Jennings L, Shippee ND, Richardson CR, Bart G. Evaluation of Amphetamine-Related Hospitalizations and Associated Clinical Outcomes and Costs in the United States. JAMA Netw Open. 2018;1:e183758\u2013e183758. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.3758","journal-title":"JAMA Netw Open"},{"key":"1271_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/00952990601175029","volume":"33","author":"C Derauf","year":"2007","unstructured":"Derauf C, LaGasse LL, Smith LM, Grant P, Shah R, Arria A, et al. Demographic and psychosocial characteristics of mothers using methamphetamine during pregnancy: preliminary results of the infant development, environment, and lifestyle study (IDEAL). Am J Drug Alcohol Abus. 2007;33:281\u2013289. https:\/\/doi.org\/10.1080\/00952990601175029","journal-title":"Am J Drug Alcohol Abus"},{"key":"1271_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/ADM.0000000000000101","volume":"9","author":"TE Wright","year":"2015","unstructured":"Wright TE, Schuetter R, Tellei J, Sauvage L. Methamphetamines and pregnancy outcomes. J addiction Med. 2015;9:111\u2013117. https:\/\/doi.org\/10.1097\/ADM.0000000000000101","journal-title":"J addiction Med"},{"key":"1271_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","volume":"70","author":"CL Mattson","year":"2021","unstructured":"Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL. Trends and geographic patterns in drug and synthetic opioid overdose deaths - United States, 2013-2019. MMWR Morb Mortal Wkly Rep. 2021;70:202\u2013207. https:\/\/doi.org\/10.15585\/mmwr.mm7006a4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1271_CR20","doi-asserted-by":"publisher","first-page":"e2710","DOI":"10.1002\/hup.2710","volume":"34","author":"M Chiang","year":"2019","unstructured":"Chiang M, Lombardi D, Du J, Makrum U, Sitthichai R, Harrington A, et al. Methamphetamine-associated psychosis: clinical presentation, biological basis, and treatment options. Hum Psychopharmacol. 2019;34:e2710 https:\/\/doi.org\/10.1002\/hup.2710","journal-title":"Hum Psychopharmacol"},{"key":"1271_CR21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.15585\/mmwr.mm6806a4","volume":"68","author":"SE Kidd","year":"2019","unstructured":"Kidd SE, Grey JA, Torrone EA, Weinstock HS. Increased methamphetamine, injection drug, and heroin use among women and heterosexual men with primary and secondary syphilis - United States, 2013\u20132017. MMWR Morb Mortal Wkly Rep. 2019;68:144\u2013148. https:\/\/doi.org\/10.15585\/mmwr.mm6806a4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1271_CR22","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/jamapsychiatry.2017.0135","volume":"74","author":"AH Ashok","year":"2017","unstructured":"Ashok AH, Mizuno Y, Volkow ND, Howes OD. Association of stimulant use with dopaminergic alterations in users of cocaine, amphetamine, or methamphetamine: a systematic review and meta-analysis. JAMA Psychiatry. 2017;74:511\u2013519. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.0135","journal-title":"JAMA Psychiatry"},{"key":"1271_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa2020214","volume":"384","author":"MH Trivedi","year":"2021","unstructured":"Trivedi MH, Walker R, Ling W, dela Cruz A, Sharma G, Carmody T, et al. Bupropion and naltrexone in methamphetamine use disorder. N. Engl J Med. 2021;384:140\u2013153. https:\/\/doi.org\/10.1056\/NEJMoa2020214","journal-title":"N. Engl J Med"},{"key":"1271_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/add.15509","author":"FA Perez","year":"2021","unstructured":"Perez FA, Blythe S, Wouldes T, McNamara K, Black KI, Oei JL. Prenatal methamphetamine-impact on the mother and child-a review. Addiction. 2021. https:\/\/doi.org\/10.1111\/add.15509","journal-title":"Addiction"},{"key":"1271_CR25","first-page":"762","volume":"296","author":"JM Brown","year":"2001","unstructured":"Brown JM, Hanson GR, Fleckenstein AE. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants. J Pharmacol Exp therapeutics. 2001;296:762\u2013767.","journal-title":"J Pharmacol Exp therapeutics"},{"key":"1271_CR26","doi-asserted-by":"publisher","first-page":"12070","DOI":"10.1074\/jbc.M212815200","volume":"278","author":"H Khoshbouei","year":"2003","unstructured":"Khoshbouei H, Wang H, Lechleiter JD, Javitch JA, Galli A. Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism. J Biol Chem. 2003;278:12070\u201312077. https:\/\/doi.org\/10.1074\/jbc.M212815200","journal-title":"J Biol Chem"},{"key":"1271_CR27","doi-asserted-by":"publisher","first-page":"5916","DOI":"10.1523\/JNEUROSCI.21-16-05916.2001","volume":"21","author":"Y Schmitz","year":"2001","unstructured":"Schmitz Y, Lee CJ, Schmauss C, Gonon F, Sulzer D. Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores. J Neurosci: Off J Soc Neurosci. 2001;21:5916\u20135924.","journal-title":"J Neurosci: Off J Soc Neurosci"},{"key":"1271_CR28","doi-asserted-by":"publisher","first-page":"6850","DOI":"10.1073\/pnas.110035297","volume":"97","author":"C Saunders","year":"2000","unstructured":"Saunders C, Ferrer JV, Shi L, Chen J, Merrill G, Lamb ME, et al. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc Natl Acad Sci USA. 2000;97:6850\u20136855. https:\/\/doi.org\/10.1073\/pnas.110035297","journal-title":"Proc Natl Acad Sci USA"},{"key":"1271_CR29","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/0006-2952(76)90432-9","volume":"25","author":"TJ Mantle","year":"1976","unstructured":"Mantle TJ, Tipton KF, Garrett NJ. Inhibition of monoamine oxidase by amphetamine and related compounds. Biochemical Pharmacol. 1976;25:2073\u20132077. https:\/\/doi.org\/10.1016\/0006-2952(76)90432-9","journal-title":"Biochemical Pharmacol"},{"key":"1271_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/227075a0","volume":"227","author":"AJ Mandell","year":"1970","unstructured":"Mandell AJ, Morgan M. Amphetamine induced increase in tyrosine hydroxylase activity. Nature. 1970;227:75\u201376. https:\/\/doi.org\/10.1038\/227075a0","journal-title":"Nature"},{"key":"1271_CR31","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/j.1360-0443.2009.02564.x","volume":"104","author":"CC Cruickshank","year":"2009","unstructured":"Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction. 2009;104:1085\u20131099. https:\/\/doi.org\/10.1111\/j.1360-0443.2009.02564.x","journal-title":"Addiction"},{"key":"1271_CR32","first-page":"301","volume":"31","author":"AM Barr","year":"2006","unstructured":"Barr AM, Panenka WJ, MacEwan GW, Thornton AE, Lang DJ, Honer WG, et al. The need for speed: an update on methamphetamine. addiction J psychiatry Neurosci: JPN. 2006;31:301\u2013313.","journal-title":"addiction J psychiatry Neurosci: JPN"},{"key":"1271_CR33","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1080\/10550490050148053","volume":"9","author":"SL Simon","year":"2000","unstructured":"Simon SL, Carnell J, Brethen P, Rawson R, Ling W. Cognitive impairment in individuals currently using methamphetamine. Am J Addictions. 2000;9:222\u2013231.","journal-title":"Am J Addictions"},{"key":"1271_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s0197-0186(97)00031-4","volume":"32","author":"JL Cadet","year":"1998","unstructured":"Cadet JL, Brannock C. Free radicals and the pathobiology of brain dopamine systems. Neurochem Int. 1998;32:117\u2013131. https:\/\/doi.org\/10.1016\/s0197-0186(97)00031-4","journal-title":"Neurochem Int"},{"key":"1271_CR35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11064-017-2318-5","volume":"43","author":"EJ Shin","year":"2018","unstructured":"Shin EJ, Tran HQ, Nguyen PT, Jeong JH, Nah SY, Jang CG, et al. Role of mitochondria in methamphetamine-induced dopaminergic neurotoxicity: involvement in oxidative stress, neuroinflammation, and pro-apoptosis-a review. Neurochem Res. 2018;43:66\u201378. https:\/\/doi.org\/10.1007\/s11064-017-2318-5","journal-title":"Neurochem Res"},{"key":"1271_CR36","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.neuroscience.2012.03.004","volume":"210","author":"M Lin","year":"2012","unstructured":"Lin M, Chandramani-Shivalingappa P, Jin H, Ghosh A, Anantharam V, Ali S, et al. Methamphetamine-induced neurotoxicity linked to ubiquitin-proteasome system dysfunction and autophagy-related changes that can be modulated by protein kinase C delta in dopaminergic neuronal cells. Neuroscience. 2012;210:308\u2013332. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.03.004","journal-title":"Neuroscience"},{"key":"1271_CR37","doi-asserted-by":"publisher","first-page":"e46599","DOI":"10.1371\/journal.pone.0046599","volume":"7","author":"M Raineri","year":"2012","unstructured":"Raineri M, Gonzalez B, Goitia B, Garcia-Rill E, Krasnova IN, Cadet JL, et al. Modafinil abrogates methamphetamine-induced neuroinflammation and apoptotic effects in the mouse striatum. PLoS One. 2012;7:e46599 https:\/\/doi.org\/10.1371\/journal.pone.0046599","journal-title":"PLoS One"},{"key":"1271_CR38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.pneurobio.2015.09.011","volume":"155","author":"R Moratalla","year":"2017","unstructured":"Moratalla R, Khairnar A, Simola N, Granado N, Garc\u00eda-Montes JR, Porceddu PF, et al. Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms. Prog Neurobiol. 2017;155:149\u2013170. https:\/\/doi.org\/10.1016\/j.pneurobio.2015.09.011","journal-title":"Prog Neurobiol"},{"key":"1271_CR39","first-page":"84","volume":"9","author":"E Xu","year":"2017","unstructured":"Xu E, Liu J, Liu H, Wang X, Xiong H. Role of microglia in methamphetamine-induced neurotoxicity. Int J Physiol Pathophysiol Pharm. 2017;9:84\u2013100.","journal-title":"Int J Physiol Pathophysiol Pharm"},{"key":"1271_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-52","volume":"9","author":"A Shah","year":"2012","unstructured":"Shah A, Silverstein PS, Singh DP, Kumar A. Involvement of metabotropic glutamate receptor 5, AKT\/PI3K signaling and NF-\u03baB pathway in methamphetamine-mediated increase in IL-6 and IL-8 expression in astrocytes. J Neuroinflammation. 2012;9:52 https:\/\/doi.org\/10.1186\/1742-2094-9-52","journal-title":"J Neuroinflammation"},{"key":"1271_CR41","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fnmol.2018.00186","volume":"11","author":"X Yang","year":"2018","unstructured":"Yang X, Wang Y, Li Q, Zhong Y, Chen L, Du Y, et al. The Main Molecular Mechanisms Underlying Methamphetamine- Induced Neurotoxicity and Implications for Pharmacological Treatment. Front Mol Neurosci. 2018;11:186\u2013186. https:\/\/doi.org\/10.3389\/fnmol.2018.00186","journal-title":"Front Mol Neurosci"},{"key":"1271_CR42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0925-4927(99)00052-9","volume":"98","author":"G Bartzokis","year":"2000","unstructured":"Bartzokis G, Beckson M, Lu PH, Edwards N, Rapoport R, Wiseman E, et al. Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: implications for addiction research. Psychiatry Res: Neuroimaging. 2000;98:93\u2013102.","journal-title":"Psychiatry Res: Neuroimaging"},{"key":"1271_CR43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1001\/archpsyc.58.5.461","volume":"58","author":"G Bartzokis","year":"2001","unstructured":"Bartzokis G, Beckson M, Lu PH, Nuechterlein KH, Edwards N, Mintz J. Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. Arch Gen Psychiatry. 2001;58:461\u2013465. https:\/\/doi.org\/10.1001\/archpsyc.58.5.461","journal-title":"Arch Gen Psychiatry"},{"key":"1271_CR44","doi-asserted-by":"publisher","first-page":"6028","DOI":"10.1523\/JNEUROSCI.0713-04.2004","volume":"24","author":"PM Thompson","year":"2004","unstructured":"Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, et al. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci. 2004;24:6028\u20136036.","journal-title":"J Neurosci"},{"key":"1271_CR45","doi-asserted-by":"publisher","first-page":"8417","DOI":"10.1523\/JNEUROSCI.18-20-08417.1998","volume":"18","author":"UD McCann","year":"1998","unstructured":"McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C] WIN-35,428. J Neurosci. 1998;18:8417\u20138422.","journal-title":"J Neurosci"},{"key":"1271_CR46","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1176\/appi.ajp.158.8.1206","volume":"158","author":"Y Sekine","year":"2001","unstructured":"Sekine Y, Iyo M, Ouchi Y, Matsunaga T, Tsukada H, Okada H, et al. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry. 2001;158:1206\u20131214.","journal-title":"Am J Psychiatry"},{"key":"1271_CR47","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1176\/appi.ajp.158.3.377","volume":"158","author":"ND Volkow","year":"2001","unstructured":"Volkow ND, Chang L, Wang G-J, Fowler JS, Leonido-Yee M, Franceschi D, et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry. 2001;158:377\u2013382.","journal-title":"Am J Psychiatry"},{"key":"1271_CR48","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1176\/appi.ajp.160.9.1699","volume":"160","author":"Y Sekine","year":"2003","unstructured":"Sekine Y, Minabe Y, Ouchi Y, Takei N, Iyo M, Nakamura K, et al. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am J Psychiatry. 2003;160:1699\u20131701.","journal-title":"Am J Psychiatry"},{"key":"1271_CR49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1001\/archpsyc.61.1.73","volume":"61","author":"E London","year":"2004","unstructured":"London E, Simon S, Berman S, Mandelkern M, Lichtman A, Bramen J, et al. Regional cerebral dysfunction associated with mood disturbances in abstinent methamphetamine abusers. Arch Gen Psychiatry. 2004;61:73\u201384.","journal-title":"Arch Gen Psychiatry"},{"key":"1271_CR50","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.ajem.2018.01.001","volume":"36","author":"JR Richards","year":"2018","unstructured":"Richards JR, Harms BN, Kelly A, Turnipseed SD. Methamphetamine use and heart failure: prevalence, risk factors, and predictors. Am J Emerg Med. 2018;36:1423\u20131428. https:\/\/doi.org\/10.1016\/j.ajem.2018.01.001","journal-title":"Am J Emerg Med"},{"key":"1271_CR51","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s004149900088","volume":"113","author":"Y Maeno","year":"2000","unstructured":"Maeno Y, Iwasa M, Inoue H, Koyama H, Matoba R. Methamphetamine induces an increase in cell size and reorganization of myofibrils in cultured adult rat cardiomyocytes. Int J Leg Med. 2000;113:201\u2013207.","journal-title":"Int J Leg Med"},{"key":"1271_CR52","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0033-0620(74)90028-0","volume":"16","author":"J Metcalfe","year":"1974","unstructured":"Metcalfe J, Ueland K. Maternal cardiovascular adjustments to pregnancy. Prog Cardiovasc Dis. 1974;16:363\u2013374. https:\/\/doi.org\/10.1016\/0033-0620(74)90028-0","journal-title":"Prog Cardiovasc Dis"},{"key":"1271_CR53","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/0002-9378(69)90637-1","volume":"104","author":"K Ueland","year":"1969","unstructured":"Ueland K, Novy MJ, Peterson EN, Metcalfe J. Maternal cardiovascular dynamics. IV. The influence of gestational age on the maternal cardiovascular response to posture and exercise. Am J Obstet Gynecol. 1969;104:856\u2013864.","journal-title":"Am J Obstet Gynecol"},{"key":"1271_CR54","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1001\/jama.1991.03460150072026","volume":"265","author":"DJ Burchfield","year":"1991","unstructured":"Burchfield DJ, Lucas VW, Abrams RM, Miller RL, DeVane CL. Disposition and pharmacodynamics of methamphetamine in pregnant sheep. Jama. 1991;265:1968\u20131973. https:\/\/doi.org\/10.1001\/jama.1991.03460150072026","journal-title":"Jama"},{"key":"1271_CR55","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/0002-9378(93)90022-B","volume":"169","author":"AM Stek","year":"1993","unstructured":"Stek AM, Fisher BK, Baker RS, Lang U, Tseng C-Y, Clark KE. Maternal and fetal cardiovascular responses to methamphetamine in the pregnant sheep. Am J Obstet Gynecol. 1993;169:888\u2013897.","journal-title":"Am J Obstet Gynecol"},{"key":"1271_CR56","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/0002-9378(95)90654-1","volume":"173","author":"AM Stek","year":"1995","unstructured":"Stek AM, Scott Baker R, Fisher BK, Lang U, Clark KE. Fetal responses to maternal and fetal methamphetamine administration in sheep. Am J Obstet Gynecol. 1995;173:1592\u20131598. https:\/\/doi.org\/10.1016\/0002-9378(95)90654-1","journal-title":"Am J Obstet Gynecol"},{"key":"1271_CR57","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0892-0362(95)02015-2","volume":"18","author":"KD Acuff-Smith","year":"1996","unstructured":"Acuff-Smith KD, Schilling MA, Fisher JE, Vorhees CV. Stage-specific effects of prenatal d-methamphetamine exposure on behavioral and eye development in rats. Neurotoxicology Teratol. 1996;18:199\u2013215. https:\/\/doi.org\/10.1016\/0892-0362(95)02015-2","journal-title":"Neurotoxicology Teratol"},{"key":"1271_CR58","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.placenta.2003.10.017","volume":"25","author":"B Bottalico","year":"2004","unstructured":"Bottalico B, Larsson I, Brodszki J, Hernandez-Andrade E, Casslen B, Marsal K, et al. Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human. Placenta pre-eclamptic normotensive pregnancies Placenta. 2004;25:518\u2013529. https:\/\/doi.org\/10.1016\/j.placenta.2003.10.017","journal-title":"Placenta pre-eclamptic normotensive pregnancies Placenta"},{"key":"1271_CR59","doi-asserted-by":"publisher","first-page":"429.e421","DOI":"10.1016\/j.ajog.2014.06.005","volume":"211","author":"MC Gorman","year":"2014","unstructured":"Gorman MC, Orme KS, Nguyen NT, Kent EJ, Caughey AB. Outcomes in pregnancies complicated by methamphetamine use. Am J Obstet Gynecol. 2014;211:429.e421\u2013-429.e427. https:\/\/doi.org\/10.1016\/j.ajog.2014.06.005","journal-title":"Am J Obstet Gynecol"},{"key":"1271_CR60","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.lfs.2010.09.015","volume":"88","author":"V Ganapathy","year":"2011","unstructured":"Ganapathy V. Drugs of abuse and human placenta. Life Sci. 2011;88:926\u2013930. https:\/\/doi.org\/10.1016\/j.lfs.2010.09.015","journal-title":"Life Sci"},{"key":"1271_CR61","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF02395219","volume":"27","author":"E Steiner","year":"1984","unstructured":"Steiner E, Vill\u00e9n T, Hallberg M, Rane A. Amphetamine secretion in breast milk. Eur J Clin Pharm. 1984;27:123\u2013124.","journal-title":"Eur J Clin Pharm"},{"key":"1271_CR62","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4137\/SART.S14125","volume":"8","author":"M-L Brecht","year":"2014","unstructured":"Brecht M-L, Herbeck DM. Pregnancy and fetal loss reported by methamphetamine-using women. Subst Abus. 2014;8:25\u201333. https:\/\/doi.org\/10.4137\/SART.S14125","journal-title":"Subst Abus"},{"key":"1271_CR63","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1080\/02791072.2014.934978","volume":"46","author":"W Abdul-Khabir","year":"2014","unstructured":"Abdul-Khabir W, Hall T, Swanson AN, Shoptaw S. Intimate partner violence and reproductive health among methamphetamine-using women in los angeles: a qualitative pilot study. J Psychoact Drugs. 2014;46:310\u2013316. https:\/\/doi.org\/10.1080\/02791072.2014.934978","journal-title":"J Psychoact Drugs"},{"key":"1271_CR64","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/adm.0000000000000391","volume":"12","author":"D-R Kalaitzopoulos","year":"2018","unstructured":"Kalaitzopoulos D-R, Chatzistergiou K, Amylidi A-L, Kokkinidis DG, Goulis DG. Effect of methamphetamine hydrochloride on pregnancy outcome: a systematic review and meta-analysis. J Addiction Med. 2018;12:220\u2013226. https:\/\/doi.org\/10.1097\/adm.0000000000000391","journal-title":"J Addiction Med"},{"key":"1271_CR65","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pnpbp.2005.06.006","volume":"30","author":"R \u0160lamberov\u00e1","year":"2006","unstructured":"\u0160lamberov\u00e1 R, Pometlov\u00e1 M, Charousov\u00e1 P. Postnatal development of rat pups is altered by prenatal methamphetamine exposure. Prog Neuro-Psychopharmacol Biol Psychiatry. 2006;30:82\u201388. https:\/\/doi.org\/10.1016\/j.pnpbp.2005.06.006","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1271_CR66","first-page":"102","volume":"112","author":"R \u0160lamberov\u00e1","year":"2011","unstructured":"\u0160lamberov\u00e1 R, Yamamotov\u00e1 A, Schutov\u00e1 B, Hrub\u00e1 L, Pometlov\u00e1 M. Impact of prenatal methamphetamine exposure on the sensitivity to the same drug in adult male rats. Prague Med Rep. 2011;112:102\u2013114.","journal-title":"Prague Med Rep"},{"key":"1271_CR67","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/adc.2006.100156","volume":"92","author":"F Garcia-Bournissen","year":"2007","unstructured":"Garcia-Bournissen F, Rokach B, Karaskov T, Koren G. Methamphetamine detection in maternal and neonatal hair: implications for fetal safety. Arch Dis Child - Fetal Neonatal Ed. 2007;92:351\u2013355. https:\/\/doi.org\/10.1136\/adc.2006.100156","journal-title":"Arch Dis Child - Fetal Neonatal Ed"},{"key":"1271_CR68","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0892-0362(01)00151-9","volume":"23","author":"L Won","year":"2001","unstructured":"Won L, Bubula N, McCoy H, Heller A. Methamphetamine concentrations in fetal and maternal brain following prenatal exposure. Neurotoxicology Teratol. 2001;23:349\u2013354.","journal-title":"Neurotoxicology Teratol"},{"key":"1271_CR69","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/j.1651-2227.1994.tb13091.x","volume":"83","author":"M Eriksson","year":"1994","unstructured":"Eriksson M, Jonsson B, Steneroth G, Zetterstrom R. Cross-sectional growth of children whose mothers abused amphetamines during pregnancy. Acta Paediatr. 1994;83:612\u2013617. https:\/\/doi.org\/10.1111\/j.1651-2227.1994.tb13091.x","journal-title":"Acta Paediatr"},{"key":"1271_CR70","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00004703-200302000-00006","volume":"24","author":"L Smith","year":"2003","unstructured":"Smith L, Yonekura ML, Wallace T, Berman N, Kuo J, Berkowitz C. Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. J Dev Behav Pediatr. 2003;24:17\u201323. https:\/\/doi.org\/10.1097\/00004703-200302000-00006","journal-title":"J Dev Behav Pediatr"},{"key":"1271_CR71","first-page":"228","volume":"35","author":"C Chomchai","year":"2004","unstructured":"Chomchai C, Manorom N, Watanarungsan P, Yossuck P, Chomchai S. Methamphetamine abuse during pregnancy and its health impact on neonates born at Siriraj Hospital, Bangkok, Thailand. Southeast Asian J tropical Med public health. 2004;35:228\u2013231.","journal-title":"Southeast Asian J tropical Med public health"},{"key":"1271_CR72","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/jat\/21.6.515","volume":"21","author":"JL Stewart","year":"1997","unstructured":"Stewart JL, Meeker JE. Fetal and infant deaths associated with maternal methamphetamine abuse. J Anal Toxicol. 1997;21:515\u2013517. https:\/\/doi.org\/10.1093\/jat\/21.6.515","journal-title":"J Anal Toxicol"},{"key":"1271_CR73","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ijdevneu.2014.03.005","volume":"35","author":"K McDonnell-Dowling","year":"2014","unstructured":"McDonnell-Dowling K, Donlon M, Kelly JP. Methamphetamine exposure during pregnancy at pharmacological doses produces neurodevelopmental and behavioural effects in rat offspring. Int J Developmental Neurosci. 2014;35:42\u201351. https:\/\/doi.org\/10.1016\/j.ijdevneu.2014.03.005","journal-title":"Int J Developmental Neurosci"},{"key":"1271_CR74","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ijdevneu.2008.12.003","volume":"27","author":"CV Vorhees","year":"2009","unstructured":"Vorhees CV, Skelton MR, Grace CE, Schaefer TL, Graham DL, Braun AA, et al. Effects of (+)-methamphetamine on path integration and spatial learning, but not locomotor activity or acoustic startle, align with the stress hyporesponsive period in rats. Int J Developmental Neurosci. 2009;27:289\u2013298. https:\/\/doi.org\/10.1016\/j.ijdevneu.2008.12.003","journal-title":"Int J Developmental Neurosci"},{"key":"1271_CR75","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ntt.2007.09.005","volume":"30","author":"LM Smith","year":"2008","unstructured":"Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A, et al. Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicology Teratol. 2008;30:20\u201328.","journal-title":"Neurotoxicology Teratol"},{"key":"1271_CR76","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ntt.2010.10.004","volume":"33","author":"LM Smith","year":"2011","unstructured":"Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Haning W, et al. Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine. Neurotoxicol Teratol. 2011;33:176\u2013184. https:\/\/doi.org\/10.1016\/j.ntt.2010.10.004","journal-title":"Neurotoxicol Teratol"},{"key":"1271_CR77","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.physbeh.2008.12.013","volume":"96","author":"VB Thompson","year":"2009","unstructured":"Thompson VB, Heiman J, Chambers JB, Benoit SC, Buesing WR, Norman MK, et al. Long-term behavioral consequences of prenatal MDMA exposure. Physiol Behav. 2009;96:593\u2013601.","journal-title":"Physiol Behav"},{"key":"1271_CR78","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1001\/archpedi.1963.02080050327013","volume":"106","author":"S Sussman","year":"1963","unstructured":"Sussman S. Narcotic and methamphetamine use during pregnancy. Eff newborn infants Am J Dis Child. 1963;106:325\u2013330. https:\/\/doi.org\/10.1001\/archpedi.1963.02080050327013","journal-title":"Eff newborn infants Am J Dis Child"},{"key":"1271_CR79","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1055\/s-0032-1304818","volume":"29","author":"R Shah","year":"2012","unstructured":"Shah R, Diaz SD, Arria A, LaGasse LL, Derauf C, Newman E, et al. Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes. Am J Perinatol. 2012;29:391\u2013400.","journal-title":"Am J Perinatol"},{"key":"1271_CR80","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1542\/peds.2005-2564","volume":"118","author":"LM Smith","year":"2006","unstructured":"Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A, et al. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics. 2006;118:1149\u20131156.","journal-title":"Pediatrics"},{"key":"1271_CR81","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jpeds.2010.04.024","volume":"157","author":"D Nguyen","year":"2010","unstructured":"Nguyen D, Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, et al. Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study. J pediatrics. 2010;157:337\u2013339.","journal-title":"J pediatrics"},{"key":"1271_CR82","unstructured":"Gargari, SS, Fallahian, M, Haghighi, L, Hosseinnezhad-Yazdi, M, Dashti, E & Dolan, K. Maternal and neonatal complications of substance abuse in Iranian pregnant women. Acta Med Iran. 2012;50:411\u201316."},{"key":"1271_CR83","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0022-3476(87)80125-7","volume":"111","author":"AS Oro","year":"1987","unstructured":"Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J pediatrics. 1987;111:571\u2013578.","journal-title":"J pediatrics"},{"key":"1271_CR84","first-page":"541","volume":"72","author":"BB Little","year":"1988","unstructured":"Little BB, Snell LM, Gilstrap L 3rd. Methamphetamine abuse during pregnancy: outcome and fetal effects. Obstet Gynecol. 1988;72:541\u2013544.","journal-title":"Obstet Gynecol"},{"key":"1271_CR85","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1136\/bmj.1.5748.523","volume":"1","author":"MM Nelson","year":"1971","unstructured":"Nelson MM, Forfar JO. Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. Br Med J. 1971;1:523\u2013527.","journal-title":"Br Med J"},{"key":"1271_CR86","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/S0140-6736(70)91765-4","volume":"1","author":"J Nora","year":"1970","unstructured":"Nora J, Vargo T, Nora A, Love K, Mcnamara D. Dexamphetamine: a possible environmental trigger in cardiovascular malformations. Lancet (Lond, Engl). 1970;1:1290\u20131291.","journal-title":"Lancet (Lond, Engl)"},{"key":"1271_CR87","unstructured":"Heinonen OP, Slone D & Shapiro S Birth defects and drugs in pregnancy. (Publishing Sciences Group Inc., Littleton, Massachusetts, USA, 1977)."},{"key":"1271_CR88","unstructured":"Sankaran DL, Satyan. Cardiovascular effects of prenatal methamphetamine exposure. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04616625 (2020)."},{"key":"1271_CR89","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/S0022-3476(89)80661-4","volume":"115","author":"SD Dixon","year":"1989","unstructured":"Dixon SD, Bejar R. Echoencephalographic findings in neonates assciiated with maternal cocaine and methamphetamine use: Incidence and clinical correlates. J Pediatrics. 1989;115:770\u2013778. https:\/\/doi.org\/10.1016\/S0022-3476(89)80661-4","journal-title":"J Pediatrics"},{"key":"1271_CR90","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.braindev.2018.08.010","volume":"41","author":"E Maranella","year":"2019","unstructured":"Maranella E, Mareri A, Nardi V, Di Natale C, Di Luca L, Conte E, et al. Severe neurologic and hepatic toxicity in a newborn prenatally exposed to methamphetamine. A case report. Brain Dev. 2019;41:191\u2013194. https:\/\/doi.org\/10.1016\/j.braindev.2018.08.010","journal-title":"Brain Dev"},{"key":"1271_CR91","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.neuroimage.2009.06.062","volume":"48","author":"L Chang","year":"2009","unstructured":"Chang L, Cloak C, Jiang CS, Farnham S, Tokeshi B, Buchthal S, et al. Altered neurometabolites and motor integration in children exposed to methamphetamine in utero. Neuroimage. 2009;48:391\u2013397. https:\/\/doi.org\/10.1016\/j.neuroimage.2009.06.062","journal-title":"Neuroimage"},{"key":"1271_CR92","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jpeds.2015.11.070","volume":"170","author":"N Eze","year":"2016","unstructured":"Eze N, Smith LM, LaGasse LL, Derauf C, Newman E, Arria A, et al. School-aged outcomes following prenatal methamphetamine exposure: 7.5-year follow-up from the infant development, environment, and lifestyle study. J pediatrics. 2016;170:34\u201338.e31. https:\/\/doi.org\/10.1016\/j.jpeds.2015.11.070","journal-title":"J pediatrics"},{"key":"1271_CR93","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ntt.2015.07.006","volume":"51","author":"LM Smith","year":"2015","unstructured":"Smith LM, Diaz S, LaGasse LL, Wouldes T, Derauf C, Newman E, et al. Developmental and behavioral consequences of prenatal methamphetamine exposure: a review of the Infant Development, Environment, and Lifestyle (IDEAL) study. Neurotoxicol Teratol. 2015;51:35\u201344. https:\/\/doi.org\/10.1016\/j.ntt.2015.07.006","journal-title":"Neurotoxicol Teratol"},{"key":"1271_CR94","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.drugalcdep.2019.01.032","volume":"198","author":"KP Morie","year":"2019","unstructured":"Morie KP, Crowley MJ, Mayes LC, Potenza MN. Prenatal drug exposure from infancy through emerging adulthood: results from neuroimaging. Drug alcohol Depend. 2019;198:39\u201353. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.01.032","journal-title":"Drug alcohol Depend"},{"key":"1271_CR95","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11011-017-0135-9","volume":"33","author":"FL Warton","year":"2018","unstructured":"Warton FL, Taylor PA, Warton CMR, Molteno CD, Wintermark P, Lindinger NM, et al. Prenatal methamphetamine exposure is associated with corticostriatal white matter changes in neonates. Metab brain Dis. 2018;33:507\u2013522. https:\/\/doi.org\/10.1007\/s11011-017-0135-9","journal-title":"Metab brain Dis"},{"key":"1271_CR96","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1469-8749.1993.tb11731.x","volume":"35","author":"RL Hansen","year":"1993","unstructured":"Hansen RL, Struthers JM, Gospe SM Jr. Visual evoked potentials and visual processing in stimulant drug\u2010exposed infants. Developmental Med Child Neurol. 1993;35:798\u2013805.","journal-title":"Developmental Med Child Neurol"},{"key":"1271_CR97","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1542\/peds.2011-2209","volume":"129","author":"LL LaGasse","year":"2012","unstructured":"LaGasse LL, Derauf C, Smith LM, Newman E, Shah R, Neal C, et al. Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age. Pediatrics. 2012;129:681\u2013688. https:\/\/doi.org\/10.1542\/peds.2011-2209","journal-title":"Pediatrics"},{"key":"1271_CR98","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.jpeds.2012.02.002","volume":"161","author":"C Derauf","year":"2012","unstructured":"Derauf C, LaGasse LL, Smith LM, Newman E, Shah R, Neal CR, et al. Prenatal methamphetamine exposure and inhibitory control among young school-age children. J pediatrics. 2012;161:452\u2013459.","journal-title":"J pediatrics"},{"key":"1271_CR99","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ntt.2014.02.004","volume":"42","author":"TA Wouldes","year":"2014","unstructured":"Wouldes TA, LaGasse LL, Huestis MA, DellaGrotta S, Dansereau LM, Lester BM. Prenatal methamphetamine exposure and neurodevelopmental outcomes in children from 1 to 3 years. Neurotoxicology Teratol. 2014;42:77\u201384.","journal-title":"Neurotoxicology Teratol"},{"key":"1271_CR100","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.comppsych.2017.08.003","volume":"80","author":"MA Kwiatkowski","year":"2018","unstructured":"Kwiatkowski MA, Donald KA, Stein DJ, Ipser J, Thomas KG, Roos A. Cognitive outcomes in prenatal methamphetamine exposed children aged six to seven years. Compr psychiatry. 2018;80:24\u201333.","journal-title":"Compr psychiatry"},{"key":"1271_CR101","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/DBP.0b013e318277a1c5","volume":"34","author":"ZN Kiblawi","year":"2013","unstructured":"Kiblawi ZN, Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, et al. The effect of prenatal methamphetamine exposure on attention as assessed by continuous performance tests: results from the Infant Development, Environment, and Lifestyle study. J Dev Behav Pediatr. 2013;34:31\u201337. https:\/\/doi.org\/10.1097\/DBP.0b013e318277a1c5","journal-title":"J Dev Behav Pediatr"},{"key":"1271_CR102","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1037\/a0030157","volume":"27","author":"B Abar","year":"2013","unstructured":"Abar B, LaGasse LL, Derauf C, Newman E, Shah R, Smith LM, et al. Examining the relationships between prenatal methamphetamine exposure, early adversity, and child neurobehavioral disinhibition. Psychol Addict Behav. 2013;27:662\u2013673. https:\/\/doi.org\/10.1037\/a0030157","journal-title":"Psychol Addict Behav"},{"key":"1271_CR103","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/mp.2017.143","volume":"22","author":"X Huang","year":"2017","unstructured":"Huang X, Chen YY, Shen Y, Cao X, Li A, Liu Q, et al. Methamphetamine abuse impairs motor cortical plasticity and function. Mol psychiatry. 2017;22:1274\u20131281. https:\/\/doi.org\/10.1038\/mp.2017.143","journal-title":"Mol psychiatry"},{"key":"1271_CR104","doi-asserted-by":"publisher","first-page":"4982453","DOI":"10.1155\/2018\/4982453","volume":"2018","author":"F Limanaqi","year":"2018","unstructured":"Limanaqi F, Gambardella S, Biagioni F, Busceti CL, Fornai F. Epigenetic Effects Induced by Methamphetamine and Methamphetamine-Dependent Oxidative Stress. Oxid Med Cell Longev. 2018;2018:4982453 https:\/\/doi.org\/10.1155\/2018\/4982453","journal-title":"Oxid Med Cell Longev"},{"key":"1271_CR105","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.pscychresns.2004.06.004","volume":"132","author":"L Chang","year":"2004","unstructured":"Chang L, Smith LM, LoPresti C, Yonekura ML, Kuo J, Walot I, et al. Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res. 2004;132:95\u2013106. https:\/\/doi.org\/10.1016\/j.pscychresns.2004.06.004","journal-title":"Psychiatry Res"},{"key":"1271_CR106","unstructured":"ACOG. Methamphetamine Abuse in Women of Reproductive Age. ACOG Committee Opinion No. 479. https:\/\/www.acog.org\/Clinical-Guidance-and-Publications\/Committee-Opinions\/Committee-on-Health-Care-for-Underserved-Women\/Methamphetamine-Abuse-in-Women-of-Reproductive-Age?IsMobileSet=false, 1-5 (2011, reaffirmed 2021)."},{"key":"1271_CR107","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1001\/jamapsychiatry.2018.2556","volume":"75","author":"M Wade","year":"2018","unstructured":"Wade M, Fox NA, Zeanah CH, Nelson CA. Effect of foster care intervention on trajectories of general and specific psychopathology among children with histories of institutional rearing: a randomized clinical trialeffect of foster care intervention on psychopathology among children with histories of institutional rearingeffect of foster care intervention on psychopathology among children with histories of institutional rearing. JAMA Psychiatry. 2018;75:1137\u20131145. https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.2556","journal-title":"JAMA Psychiatry"},{"key":"1271_CR108","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/j.1467-8624.2011.01604.x","volume":"82","author":"J Windsor","year":"2011","unstructured":"Windsor J, Benigno JP, Wing CA, Carroll PJ, Koga SF, Nelson CA 3rd, et al. Effect of foster care on young children\u2019s language learning. Child Dev. 2011;82:1040\u20131046. https:\/\/doi.org\/10.1111\/j.1467-8624.2011.01604.x","journal-title":"Child Dev"},{"key":"1271_CR109","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/ajop.12007","volume":"83","author":"J Twomey","year":"2013","unstructured":"Twomey J, LaGasse L, Derauf C, Newman E, Shah R, Smith L, et al. Prenatal methamphetamine exposure, home environment, and primary caregiver risk factors predict child behavioral problems at 5 years. Am J Orthopsychiatry. 2013;83:64.","journal-title":"Am J Orthopsychiatry"},{"key":"1271_CR110","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1080\/15548732.2012.683364","volume":"6","author":"N Messina","year":"2012","unstructured":"Messina N, Jeter K. Parental methamphetamine use and manufacture: child and familial outcomes. J public child Welf. 2012;6:296\u2013312.","journal-title":"J public child Welf"},{"key":"1271_CR111","doi-asserted-by":"publisher","unstructured":"Chu EK, Smith LM, Derauf C, Newman E, Neal CR, Arria AM, et al. Behavior problems during early childhood in children with prenatal methamphetamine exposure. Pediatrics. 2020;146:e20190270. https:\/\/doi.org\/10.1542\/peds.2019-0270","DOI":"10.1542\/peds.2019-0270"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41372-021-01271-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-021-01271-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-021-01271-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T23:03:13Z","timestamp":1646953393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-021-01271-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":111,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1271"],"URL":"https:\/\/doi.org\/10.1038\/s41372-021-01271-8","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,16]]},"assertion":[{"value":"23 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}